2020 Global Respiratory Disease testing Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV & Tuberculosis - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 24, 2020--
The “2020 Global Respiratory Disease testing Market: US, Europe, Japan - Supplier Shares and Sales Segment Forecasts - Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis” report has been added to ResearchAndMarkets.com’s offering.
This new 366-page report from the author contains 108 tables and provides analysis of the global respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
About this Report
This report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.
The report provides test volume and sales forecasts by country and market segment, including:
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test and country.
Also, the report:
For more information about this report visit https://www.researchandmarkets.com/r/8oqjfj
View source version on businesswire.com:https://www.businesswire.com/news/home/20200124005386/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2020.
PUB: 01/24/2020 12:52 PM/DISC: 01/24/2020 12:52 PM